|
WO2020264405A1
|
|
Rho kinase inhibitors and compositions and methods of use thereof
|
|
WO2020252047A1
|
|
Solid forms of a kynurenine-3-monooxygenase inhibitor
|
|
WO2020176424A1
|
|
Compounds for targeting mutant huntingtin protein and uses thereof
|
|
CA2995847A1
|
|
Probes for imaging huntingtin protein
|
|
WO2016179554A1
|
|
Histone deacetylase inhibitors and compositions and methods of use thereof
|
|
EP3291809A1
|
|
Histone deacetylase inhibitors and compositions and methods of use thereof
|
|
MX2017002704A
|
|
Probes for imaging huntingtin protein.
|
|
CN107108534A
|
|
Probe for being imaged Huntington protein
|
|
BR112017004134A2
|
|
"Huntingtin protein imaging probes"
|
|
CN107105667A
|
|
Probe for being imaged Huntington protein
|
|
BR112017000922A2
|
|
methods and compositions for treating hiv-related disorders
|
|
US2017101402A1
|
|
Histone deacetylase inhibitors and compositions and methods of use thereof
|
|
EP3049389A1
|
|
Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
|
|
WO2015047982A2
|
|
Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
|
|
EP2968233A1
|
|
Histone deacetylase inhibitors and compositions and methods of use thereof
|
|
US2016024019A1
|
|
Histone deacetylase inhibitors and compositions and methods of use thereof
|
|
WO2014159218A1
|
|
Histone deacetylase inhibitors and compositions
|
|
WO2014159214A1
|
|
Histone deacetylase inhibitors and compositions and methods of use thereof
|
|
TW201418198A
|
|
Transglutaminase TG2 inhibitors, pharmaceutical compositions, and methods of use thereof
|
|
TW201408628A
|
|
Histone deacetylase inhibitors and compositions and methods of use thereof
|
